Evaluation Safety and Explore Efficacy Long-term Follow-up Study on Subjects Receiving SMUP-IA-01 or Active Control

NCT06798727 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

84

Enrollment

INDUSTRY

Sponsor class

Conditions

Knee Osteoarthritis

Interventions

BIOLOGICAL: SMUP-IA-01(low-dose)
BIOLOGICAL: SMUP-IA-01(mid-dose)
DRUG: High Hyal Plus

Sponsor

Medipost Co Ltd.